Patent intelligence · US
US 6017893
Use of isoflavones to prevent hair loss and preserve the integrity of existing hair
Use of isoflavones to prevent hair loss and preserve the integrity of existing hair
Patent details — US 6017893
- Jurisdiction
- US
- Status
- expired
- Grant date
- Jan 25, 2000
- Expiration
- Jan 20, 2020
- Applicant
- Nature's Sunshine Products, Inc.
- Claims
- 10
- CPC classes
- A61K, A61K31/352, A61K31/565, A61K31/7048
Quick answer
US 6017893 (Use of isoflavones to prevent hair loss and preserve the integrity of existing hair) is held by Nature's Sunshine Products, Inc.. Status: expired. Granted Jan 25, 2000. Expires Jan 20, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Nature's Sunshine Products, Inc.
- Grant date
- Expiration
- Claims
- 10
- CPC classes
- A61K, A61K31/352, A61K31/565, A61K31/7048, A61K8/498
More from Nature's Sunshine Products, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12428432
Thienopyrimidine derivatives having stereo configurations and use thereof in medicine
granted -
US 12428389
Diarylamide compound and application thereof
granted -
US 12384853
Anti-HER2/PD1 bispecific antibody
granted -
US 12324812
Glucopyranosyl derivatives and their uses
granted -
US 12319748
Antibody binding to human HER2 and preparation method and use thereof
granted -
US 12312348
RET inhibitors, pharmaceutical compositions and uses thereof
granted -
US 12269886
Tetravalent bispecific antibody against PD-1 and PD-L1
granted -
US 12258317
Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof
granted
Frequently asked questions
What is US patent 6017893?
US 6017893 (Use of isoflavones to prevent hair loss and preserve the integrity of existing hair) is held by Nature's Sunshine Products, Inc.. Status: expired. Granted Jan 25, 2000. Expires Jan 20, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6017893?
Nature's Sunshine Products, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 121 pharmaceutical patents for this assignee.
When does US 6017893 expire?
Our index shows an expiration date of Jan 20, 2020 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.